CCT241736

Item number	Size	Delivery time	Price
TGM-T4428-5mg	5 mg	7 - 10 business days*	54.00€
TGM-T4428-1mL	1 ml	7 - 10 business days*	60.00€
TGM-T4428-10mg	10 mg	7 - 10 business days*	87.00€
TGM-T4428-25mg	25 mg	7 - 10 business days*	175.00€
TGM-T4428-50mg	50 mg	7 - 10 business days*	339.00€
TGM-T4428-100mg	100 mg	7 - 10 business days*	508.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also... more

Close menu

Product information "CCT241736"

Description: CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3, CCT241736, an advanced analog of CCT137690, is a preclinical development candidate for the treatment of human malignancies, and in particular AML in adults and children. Target: FLT, Aurora Kinase. Smiles: Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1. References: Bavetsias V,etal. Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia.J Med Chem. 2012 Oct 25,55(20):8721-34.

Supplier:	TargetMol
Supplier-Nr:	T4428

Properties

Application:	FLT3 inhibitor, Aurora kinase inhibitor
MW:	456.37 D
Formula:	C22H23Cl2N7

Database Information

CAS :	1402709-93-6\| Matching products
KEGG ID :	K05092 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CCT241736"

Write a review